中国病毒病杂志2024,Vol.14Issue(5) :495-499.DOI:10.16505/j.2095-0136.2024.0053

补体系统在新型冠状病毒感染发病机制及治疗中的研究进展

Research progress of complement system in the pathogenesis and treatment of COVID-19

张海燕 宋琳 李艳芳
中国病毒病杂志2024,Vol.14Issue(5) :495-499.DOI:10.16505/j.2095-0136.2024.0053

补体系统在新型冠状病毒感染发病机制及治疗中的研究进展

Research progress of complement system in the pathogenesis and treatment of COVID-19

张海燕 1宋琳 1李艳芳1
扫码查看

作者信息

  • 1. 菏泽医学专科学校,山东菏泽 274000
  • 折叠

摘要

补体系统是人体免疫屏障的重要组成部分,具有识别和消除入侵的病原微生物的功能.但是通过对重症新型冠状病毒感染(coronavirus disease 2019,COVID-19)患者的研究发现,补体过度激活引起的高炎症反应、微血管病变、血小板-中性粒细胞活化和血栓形成会使COVID-19病情加重.由于补体在病情进展中的双重作用,使其有望成为COVID-19治疗新靶点的潜能,一些补体抑制剂在COVID-19治疗中已经取得了明显的效果.本文将补体系统与新型冠状病毒感染的相关性研究进行综述.

Abstract

The complement system is an important part of the human immune barrier and has the function of identifying and eliminating invading pathogenic microorganisms.However,studies on patients with coronavirus disease 2019(COVID-19)have found that excessive activation of the complement system leads to heightened inflammatory responses,microvascular damage,platelet-neutrophil activation,and thrombosis,exacerbating the severity of the disease.Given the dual role of complement in disease progression,it has the potential to become a new therapeutic target of COVID-19.Several complement inhibitors have already achieved obvious effects in the treatment of COVID-19.This review summarizes the relationship between the complement system and SARS-COV-2 infection,highlighting its potential as a therapeutic target.

关键词

新型冠状病毒感染/补体系统/机制/治疗新靶点

Key words

Coronavirus disease 2019(COVID-19)/Complement system/Mechanism/New therapeutic targets

引用本文复制引用

出版年

2024
中国病毒病杂志

中国病毒病杂志

CSTPCDCSCD
影响因子:0.734
ISSN:
段落导航相关论文